TR200000734T2 - Seçici bir 5-HT1A/5-HT1B antagonistinin veya kısmi antagonistinin bir bileşimi. - Google Patents

Seçici bir 5-HT1A/5-HT1B antagonistinin veya kısmi antagonistinin bir bileşimi.

Info

Publication number
TR200000734T2
TR200000734T2 TR2000/00734T TR200000734T TR200000734T2 TR 200000734 T2 TR200000734 T2 TR 200000734T2 TR 2000/00734 T TR2000/00734 T TR 2000/00734T TR 200000734 T TR200000734 T TR 200000734T TR 200000734 T2 TR200000734 T2 TR 200000734T2
Authority
TR
Turkey
Prior art keywords
antagonist
ht1a
selective
composition
ht1b
Prior art date
Application number
TR2000/00734T
Other languages
English (en)
Inventor
Berg Stefan
Ross Svante
Thorberg Seth-Olov
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TR200000734T2 publication Critical patent/TR200000734T2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bulus, formül (I)'e sahip olan ki bu formülde, R1 n-propil veya siklobutildir, R2 izopropil, tersiyer butil, siklobutil, siklopentil veya siklohekzildir, R3 hidrojen ve R4 hidrojen ya da metildir ve (R)-enantiyomeri seklindedir.
TR2000/00734T 1997-09-18 1998-09-09 Seçici bir 5-HT1A/5-HT1B antagonistinin veya kısmi antagonistinin bir bileşimi. TR200000734T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703374A SE9703374D0 (sv) 1997-09-18 1997-09-18 A new combination

Publications (1)

Publication Number Publication Date
TR200000734T2 true TR200000734T2 (tr) 2000-11-21

Family

ID=20408294

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00734T TR200000734T2 (tr) 1997-09-18 1998-09-09 Seçici bir 5-HT1A/5-HT1B antagonistinin veya kısmi antagonistinin bir bileşimi.

Country Status (29)

Country Link
US (1) US6159972A (tr)
EP (1) EP1021183B1 (tr)
JP (1) JP2001516717A (tr)
KR (1) KR20010024075A (tr)
CN (1) CN1182847C (tr)
AR (1) AR015447A1 (tr)
AT (1) ATE261728T1 (tr)
AU (1) AU752718B2 (tr)
BR (1) BR9812234A (tr)
CA (1) CA2302383A1 (tr)
DE (1) DE69822490T2 (tr)
DK (1) DK1021183T3 (tr)
EE (1) EE04142B1 (tr)
ES (1) ES2216307T3 (tr)
HU (1) HUP0100401A3 (tr)
IL (1) IL134774A0 (tr)
IS (1) IS5408A (tr)
MY (1) MY116281A (tr)
NO (1) NO20001398L (tr)
NZ (1) NZ503174A (tr)
PL (1) PL339370A1 (tr)
PT (1) PT1021183E (tr)
RU (1) RU2215528C2 (tr)
SE (1) SE9703374D0 (tr)
SK (1) SK2842000A3 (tr)
TR (1) TR200000734T2 (tr)
TW (1) TW568786B (tr)
WO (1) WO1999013876A1 (tr)
ZA (1) ZA987810B (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
SE9703375D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
WO2002066454A1 (fr) * 2001-02-21 2002-08-29 Sankyo Company, Limited Derives de chromene
DK1408976T5 (da) * 2001-07-20 2011-01-10 Psychogenics Inc Behandling af ADHD (Attention deficit hyperactivity disorder)
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
USD969017S1 (en) 2021-06-28 2022-11-08 Koninklijke Asscher Diamant Maatschappij B.V. Rose marquise diamond article

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA90673B (en) * 1989-02-02 1990-10-31 Yamanouchi Pharma Co Ltd Tetrahydrobenzimidazole derivatives
ES2162792T3 (es) * 1991-09-18 2002-01-16 Glaxo Group Ltd Derivados de benzanilida como antagonistas de 5-ht1d.
GB9410512D0 (en) * 1994-05-25 1994-07-13 Smithkline Beecham Plc Novel treatment
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
FI961247A0 (fi) * 1996-03-18 1996-03-18 Finnish Peroxides Ab Oy Foerfarande foer loesning av uppsvaellningsproblem i en avfalls vattenreningsanordning foer kontroll av traodartiga bakterier
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Also Published As

Publication number Publication date
DK1021183T3 (da) 2004-07-05
ZA987810B (en) 1999-02-18
EE200000143A (et) 2001-02-15
HK1032740A1 (en) 2001-08-03
HUP0100401A2 (hu) 2002-01-28
CN1182847C (zh) 2005-01-05
CA2302383A1 (en) 1999-03-25
NO20001398L (no) 2000-04-04
WO1999013876A1 (en) 1999-03-25
CN1279609A (zh) 2001-01-10
PL339370A1 (en) 2000-12-18
NZ503174A (en) 2002-03-01
IS5408A (is) 2000-03-15
DE69822490D1 (de) 2004-04-22
RU2215528C2 (ru) 2003-11-10
PT1021183E (pt) 2004-07-30
EP1021183B1 (en) 2004-03-17
AU752718B2 (en) 2002-09-26
JP2001516717A (ja) 2001-10-02
AU9192998A (en) 1999-04-05
EE04142B1 (et) 2003-10-15
DE69822490T2 (de) 2005-03-03
BR9812234A (pt) 2000-07-18
ES2216307T3 (es) 2004-10-16
SK2842000A3 (en) 2000-09-12
KR20010024075A (ko) 2001-03-26
HUP0100401A3 (en) 2003-01-28
US6159972A (en) 2000-12-12
AR015447A1 (es) 2001-05-02
ATE261728T1 (de) 2004-04-15
EP1021183A1 (en) 2000-07-26
TW568786B (en) 2004-01-01
SE9703374D0 (sv) 1997-09-18
IL134774A0 (en) 2001-04-30
MY116281A (en) 2003-12-31
NO20001398D0 (no) 2000-03-17

Similar Documents

Publication Publication Date Title
ATE218859T1 (de) Liganden des neuropeptids y
TR199902946T2 (tr) Türetilmis 3-siyano kinolinler.
NL350077I1 (nl) Cyprosulfamide
DK0892780T3 (da) m-Amidinophenylanaloger som faktor Xa-inhibitorer
MY136789A (en) Metalloproteinase inhibitors
DE59903442D1 (de) Azidfreie, gaserzeugende Zusammensetzung
SI1392642T1 (sl) Nove spojine kot protivnetna, imunomodulacijska in antiproliferativna sredstva
DK1040108T3 (da) Orthoanthranilamidderivater som antikoagulanter
SE0004245D0 (sv) Novel compounds and their use
TR200002320T2 (tr) Sert termoplastik poliüretan içeren bileşimlerden elastomerler.
TR199801866A1 (tr) Yeni piperazin ve piperidin bilesikleri
TR200201613T2 (tr) Antitümör tesirli 2-(1H-indol-3-il)-2-okso asetamidler
ATE318810T1 (de) 3-oxadiazol-5-yl-1-aminoalkyl-1h-indolderivate
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
TR200000734T2 (tr) Seçici bir 5-HT1A/5-HT1B antagonistinin veya kısmi antagonistinin bir bileşimi.
BR9902084A (pt) Heterociclos.
DK1204659T3 (da) Serotonerge benzofuraner
BG105539A (bg) Елетриптан хидробромид монохидрат
ATE287403T1 (de) 6-phenylbenzonaphthyidine
MXPA02011234A (es) Nuevas bases de oxidacion 2,5-diaminopiridina utiles para el tinte de las fibras queratinicas.
BR9907426A (pt) Tetrahidronaftalenos
TR200402754T4 (tr) Yeni benzosultam oksazolidinon antibakteriyel maddeler.
TR200002755T2 (tr) Aracı hazırlamak için süreç.
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
TR200003203T2 (tr) Karboksaldehitin saflaştırılması